Journals / Medical Records / 2024 / Cilt: 6 Sayı: 3

Explainable Machine Learning Models for Predicting Recurrence in Differentiated Thyroid Cancer

Pages
468–473
Publication Date
2024-09-24
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, this study successfully identified key risk factors for DTC recurrence using XAI models, providing interpretable insights for clinical decision-making and potential for personalized treatment strategies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Differentiated thyroid cancer (DTC) is a common type of cancer that originates in the thyroid gland.
📊
Key Findings & Data:Material and Method: The study utilized a dataset from the UCI Machine Learning Repository, which included 383 patients and 13 candidate predictors.
💡
Conclusion & Impact:Conclusion: In conclusion, this study successfully identified key risk factors for DTC recurrence using XAI models, providing interpretable insights for clinical decision-making and potential for personalized treatment strategies.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Differentiated thyroid cancer · explainable machine learning · risk factors

Abstract

Aim: Differentiated thyroid cancer (DTC) is a common type of cancer that originates in the thyroid gland. This study aimed to predict the recurrence of differentiated thyroid carcinoma, in patient with well-DTC, using explainable machine learning (XAI) models. Material and Method: The study utilized a dataset from the UCI Machine Learning Repository, which included 383 patients and 13 candidate predictors. After a variable selection process using distance correlation, only four predictors (Response, Risk, T, and N) were retained for model building. Two XAI models, Fast Interpretable Greedy-Tree Sums (FIGS) and Explainable Boosting Machines (EBM), were employed. Results: The EBM model slightly outperformed the FIGS model in terms of accuracy. The study found that the most influential predictors of Well-DTC recurrence were the response to DTC treatment, risk status according to the American Thyroid Association classification, tumor size (T), and lymph node metastasis (N). Conclusion: In conclusion, this study successfully identified key risk factors for DTC recurrence using XAI models, providing interpretable insights for clinical decision-making and potential for personalized treatment strategies.

🔖

Cite This Article

Arslan, A. K., Çolak, C. (2024). Explainable Machine Learning Models for Predicting Recurrence in Differentiated Thyroid Cancer. Medical Records, Cilt: 6 Sayı: 3, 468–473. https://doi.org/10.37990/medr.1525801

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. The Lancet. 2016;388:2783-95.
  2. Nguyen QT, Lee EJ, Huang MG, et al. Diagnosis and treatment of patients with thyroid cancer. Am Health Drug Benefits. 2015;8:30-40.
  3. Chen DW, Lang BH, McLeod DS, et al. Thyroid cancer. Lancet. 2023;401:1531-44.
  4. Burns WR, Zeiger MA. Differentiated thyroid cancer. Semin Oncol. 2010:557-66.
  5. Schmidbauer B, Menhart K, Hellwig D, Grosse J. Differentiated thyroid cancer—treatment: state of the art. Int J Mol Sci. 2017;18:1292.
  6. Panagiotakopoulos T, Chorti A, Pliakos I, et al. Thyroid cancer and pregnancy: a systematic ten-year-review. Gland surgery. 2024;13:1097-107.
  7. Caron N, Clark O. Well differentiated thyroid cancer. Scand J Surg. 2004;93:261-71.
  8. Belle V, Papantonis I. Principles and practice of explainable machine learning. Frontiers in big Data. 2021;4:688969.
  9. Roscher R, Bohn B, Duarte MF, Garcke J. Explainable machine learning for scientific insights and discoveries. Ieee Access. 2020;8:42200-16.
  10. Akter S, Mustafa HA. Analysis and interpretability of machine learning models to classify thyroid disease. Plos One. 2024;19:e0300670.
  11. Sankar S, Sathyalakshmi S. A study on the explainability of thyroid cancer prediction: SHAP values and association-rule based feature integration framework. Computers, Materials & Continua. 2024;79:3111-38.
  12. Borzooei S, Tarokhian A. Differentiated Thyroid Cancer Recurrence (Dataset). UCI Machine Learning Repository. 2023. doi: 10.24432/C5632J
  13. Borzooei S, Briganti G, Golparian M, et al. Machine learning for risk stratification of thyroid cancer patients: a 15-year cohort study. Eur Arch Otorhinolaryngol. 2024;281:2095-104.
  14. Székely GJ, Rizzo ML, Bakirov NK. Measuring and testing dependence by correlation of distances. 2007;35:2769-94.
  15. Tan YS, Singh C, Nasseri K, et al. Fast interpretable greedy-tree sums (figs). arXiv. 2023;arXiv:2201.11931.
  16. Lou Y, Caruana R, Gehrke J, Hooker G. Accurate intelligible models with pairwise interactions. 2013:623-31.
  17. Nori H, Jenkins S, Koch P, Caruana R. Interpretml: a unified framework for machine learning interpretability. arXiv. 2019;arXiv:190909223.
  18. Sudjianto A, Zhang A, Yang Z, et al. PiML toolbox for interpretable machine learning model development and diagnostics. arXiv. 2023;arXiv:230504214.
  19. Smallridge RC, Ain KB, Asa SL, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012;22:1104-39.
  20. Steinschneider M, Pitaro J, Koren S, et al. Differentiated thyroid cancer with biochemical incomplete response: clinico-pathological characteristics and long term disease outcomes. Cancers. 2021;13:5422.
  21. Campopiano MC, Ghirri A, Prete A, et al. Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response. Frontiers in Endocrinol. 2023;14:1133958.
  22. Onitilo AA, Engel JM, Lundgren CI, et al. Simplifying the TNM system for clinical use in differentiated thyroid cancer. J Clin Oncol. 2009;27:1872-8.
  23. Grønlund MP, Jensen JS, Hahn CH, et al. Risk factors for recurrence of follicular thyroid cancer: a systematic review. Thyroid. 2021;31:1523-30.
  24. Taboni S, Paderno A, Giordano D, et al. Differentiated thyroid cancer: the role of ATA nodal risk factors in N1b patients. Laryngoscope. 2021;131:E1029-34.
  25. Sibarani IJB, Suharjito S. Enhancing predictive accuracy for differentiated thyroid cancer (DTC) recurrence through advanced data mining techniques. TIN: Terapan Informatika Nusantara. 2024;5:11-22.